Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Y Saunders"'
Publikováno v:
Health Technology Assessment, Vol 8, Iss 4 (2004)
Externí odkaz:
https://doaj.org/article/744d45a4782a4896ba24c427267394ff
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Canadian Journal of Cardiology. 34:S214
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3dbbd951c713a83759976debbe9a717
https://doi.org/10.1016/j.cjca.2018.07.470
https://doi.org/10.1016/j.cjca.2018.07.470
Publikováno v:
Lung Cancer. 91:S61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48fc8c4f95381182685696fbb8f7b7c3
https://doi.org/10.1016/s0169-5002(16)30185-4
https://doi.org/10.1016/s0169-5002(16)30185-4
Publikováno v:
Palliative medicine. 20(6)
Background: Patients with advanced renal failure are increasingly opting for conservative treatment, yet little is known of their palliative care needs. Methods: We performed a cross-sectional study, examining symptom burden and quality of life in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30529fce9b04841867c9ec02a359b404
https://pubmed.ncbi.nlm.nih.gov/17060257
https://pubmed.ncbi.nlm.nih.gov/17060257
Publikováno v:
Palliative medicine. 18(5)
Systematic review of bisphosphonates for hypercalcaemia of malignancy Background: Bisphosphonates are the treatment of choice for hypercalcaemia of malignancy (HCM) but there is no consensus regarding which drug or dose should be given. We designed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5765cceeb2e251f644ef0164aceeee7c
https://pubmed.ncbi.nlm.nih.gov/15332420
https://pubmed.ncbi.nlm.nih.gov/15332420
Autor:
Y Saunders, David Wonderling, Charles Normand, Joy Ross, Polly Edmonds, S Patel, Karen Broadley
Publikováno v:
Health Technology Assessment, Vol 8, Iss 4 (2004)
Objectives: To identify evidence for the role of bisphosphonates in malignancy for the treatment of hypercalcaemia, prevention of skeletal morbidity and use in the adjuvant setting. To perform an economic review of current literature and model the co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfbc0b618487188e8f065e7a1aab0a38
https://doaj.org/article/744d45a4782a4896ba24c427267394ff
https://doaj.org/article/744d45a4782a4896ba24c427267394ff
Publikováno v:
BMJ (Clinical research ed.). 327(7408)
When a terminally ill patient develops an acute problem, risky emergency treatment may seem futile to medical staff. But sometimes patients are not ready to die. What is a good death in such circumstances and how do we achieve it? In palliative care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26dfe95111489de55c6d92fb6e749d90
https://pubmed.ncbi.nlm.nih.gov/14593058
https://pubmed.ncbi.nlm.nih.gov/14593058
Publikováno v:
Palliative medicine. 16(1)
We performed a prospective study of hospice in-patients requiring a syringe driver (SD), to determine the site duration and tolerability of metal butterfly needles compared to Teflon cannulae. Using patients as their own control, prescribed medicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f0712851f9fd82a78c044348e8840d1
https://pubmed.ncbi.nlm.nih.gov/11963447
https://pubmed.ncbi.nlm.nih.gov/11963447
Publikováno v:
BMJ. 327:469
To review the evidence for the use of bisphosphonates to reduce skeletal morbidity in cancer patients with bone metastases.Electronic databases, scanning reference lists, and consultation with experts and pharmaceutical companies. Foreign language pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083807c970871bc012d2f181f6c0cec2
https://doi.org/10.1136/bmj.327.7413.469
https://doi.org/10.1136/bmj.327.7413.469